- MiMedx To Present At 4th Annual Regen Med Investor Day
- MARIETTA, Ga., March 11, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and ...
- Regen BioPharma Inc (OTCMKTS:RGBP) On The Verge Of A Breakout
- Regen BioPharma Inc (OTCMKTS:RGBP) has exploded off 52 weeks lows and captured a lot of investor interest. While Regen has been around since 2012, the company made some real progress last year. Now investors are waking up to the company's ...
- Regen BioPharma, Inc. Completes Preclinical Experimentation for Its siRNA
- Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach.
- REGEN BIOPHARMA INCORPORATED (OTCBB:RGBP) Short Interest Decreased By 6.52%
- The stock of REGEN BIOPHARMA INCORPORATED (OTCBB:RGBP) registered a decrease of 6.52% in short interest. RGBP's total short interest was 4,300 shares in March as published by FINRA.
- Regen BioPharma, Inc.'s Immune Checkpoint Inhibitor Found to Stimulate Key
- RegenBioPharma, Inc ., (OTCBB: RGBP) and (PINK: RGBP) announced today the filing of two patent applications covering new immunological pathways activated by gene silencing of the Company's checkpoint inhibitor target NR2F6. The results, which are ...
Regen is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Regen books and related discussion.
Suggested News Resources
Related searchesamazoncom partnerships and locations
bozo the clown los angeles
guernsey pound exchange rates
peregrine falcon threats
layla bint al-minhal